Retatrutide in Boston, MA: status & local weight-loss providers
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
John Godine, MD PHD
50 STANIFORD STREET, 3RD FLOOR S50 3 DIABETES UNIT · Boston, MA 02114
5.0(1 Google review)
Nutrition and Weight Management at Boston Medical Center
732 Harrison Avenue · Boston, MA 02118
5.0(1 Google review)
Sonia Ananthakrishnan, M.D.
732 HARRISON AVE, FL 2, PRESTON BLDG · Boston, MA 02118
1.0(1 Google review)
ALINA GAVRILA, md
330 BROOKLINE AVE · Boston, MA 02215
Andrea Coviello, MD
732 HARRISON AVENUE, PRESTON, 2ND FLOOR · Boston, MA 02118
Asem Ali, MD / Mbbs
732 HARRISON AVE, FL 2, PRESTON BLDG, ENDOCRINOLOGY · Boston, MA 02118
Beth Cohen, M.D.
732 HARRISON AVE., PRESTON BLDG., 2ND FL · Boston, MA 02118
Caroline Apovian, M.D.
221 LONGWOOD AVE FL 2 · Boston, MA 02115
Chika Anekwe, MD, Mph
50 STANIFORD ST FL 4 · Boston, MA 02114
F Richard Bringhurst, MD
15 PARKMAN ST, WAC 730S · Boston, MA 02114
Florencia Halperin, M.D.
221 LONGWOOD AVE, BRIGHAM AND WOMEN'S HOSPITAL, ENDOCRINOLOGY · Boston, MA 02115
Ipsa Arora
800 WASHINGTON ST · Boston, MA 02111
ISAAC KOHANE, MD, PhD
300 LONGWOOD AVE, DIVISION OF ENDOCRINOLOGY · Boston, MA 02115
Kathryn Fantasia, M.D.
732 HARRISON AVE, FL 2, PRESTON BLDG · Boston, MA 02118
Mass General Endocrinology — Henry M. Kronenberg, MD
15 Parkman St, WAC 730 · Boston, MA 02114
Nawfal Istfan, M.D.
732 HARRISON AVE, 2ND FLOOR · Boston, MA 02118
Philip Knapp, MD
732 HARRISON AVENUE, PRESTON, 2ND FLOOR · Boston, MA 02118
Sara Alexanian, MD
732 HARRISON AVE, FL 2, PRESTON BLDG · Boston, MA 02118
Shehzad Basaria, MD
221 LONGWOOD AVE · Boston, MA 02115
Pins reflect street addresses where available; others are approximate (ZIP-level).
Be first to know when its status changes — join thousands already on the list.
Nearby markets
Learn about retatrutide
Frequently asked questions
Can I get retatrutide in Boston today?
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Boston or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
What do the providers listed for Boston actually offer?
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Are telehealth options tracked for Boston?
Yes — 30 of the 42 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Massachusetts residents; confirm with the practice.
Does being listed mean a Boston provider will prescribe retatrutide?
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
How do I hear when availability changes near Boston?
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.